Atlas Trials

Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis

Clinical trial NCT05860569 · RECRUITING

Trial details

NCT number
NCT05860569
Sponsor
GeneCradle Inc
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hypertriglyceridemia, Familial
Start date
2024-09-20
Primary completion
2026-12-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.